Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin inhalation for prosocial behavior in social anxiety disorder
NL-OMON20361Not yet recruiting
- Sponsor
- Maastricht University
- Start
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in Social Anxiety Disorder (SAD) comparing Oxytocin inhalation with Placebo inhalation (2 arms). Primary endpoints: Reciprocal self-disclosure during social interaction, Mimicry during social interaction and 2 more. Planned start Dec 2012; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NL-OMON20361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20361.